---
title: "IMDX.US (IMDX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IMDX.US/news.md"
symbol: "IMDX.US"
name: "IMDX.US"
parent: "https://longbridge.com/en/quote/IMDX.US.md"
datetime: "2026-03-08T06:55:51.596Z"
locales:
  - [en](https://longbridge.com/en/quote/IMDX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMDX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMDX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/IMDX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IMDX.US/news.md)


# IMDX.US (IMDX.US) — Related News

### [](https://longbridge.com/en/news/277665611.md)
*2026-03-03T18:24:36.000Z*
> Insight Molecular shares are trading higher after the company announced it completed several milestones to support the G

### [Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission](https://longbridge.com/en/news/277626960.md)
*2026-03-03T13:07:52.000Z*
> March 3 (Reuters) - Insight Molecular Diagnostics Inc:* INSIGHT MOLECULAR DIAGNOSTICS COMPLETES KEY MILESTONES ADVANCING

### [Base Molecular Resonance™ Technologies makes quantum detection leap after 6 months of advancement, modeling, & refinement.](https://longbridge.com/en/news/276777365.md)
*2026-02-24T18:51:05.000Z*
> In Stuart, Florida on February 24, 2026, Base Molecular Resonance™ Technologies (BMRT) revealed a significant enhancemen

### [Insight Molecular Diagnostics Raises Capital to Advance Transplant R&D](https://longbridge.com/en/news/275820647.md)
*2026-02-12T22:51:40.000Z*
> Insight Molecular Diagnostics (IMDX) raised approximately $24.5 million through a registered direct offering of 3,482,49

### [](https://longbridge.com/en/news/275637917.md)
*2026-02-11T16:44:48.000Z*
> Insight Molecular Diagnostics shares are trading lower after the company announced a $26.0 million offering of 4.526 mil

### [Insight Molecular Diagnostics Raises $26 Million in Registered Direct Offering of Shares and Pre-Funded Warrants](https://longbridge.com/en/news/275609989.md)
*2026-02-11T13:05:36.000Z*
> Insight Molecular Diagnostics Inc. has raised $26 million through a registered direct offering, selling 4,525,976 shares

### [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://longbridge.com/en/news/274511459.md)
*2026-02-02T12:05:37.000Z*
> In Monday's pre-market session, several health care stocks experienced notable movements. Gainers included Vyome Holding

### [Insight Molecular Diagnostics | 10-Q: FY2025 Q3 Revenue Misses Estimate at USD 260 K](https://longbridge.com/en/news/265216011.md)
*2025-11-10T21:35:05.000Z*